Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université Laval

$28,000.00

STEROID HORMONE SYNTHESIS/INACTIVATION AND ACTION IN TERMINAL LUNG DEVELOPMENT

EF 2017-18

Résumé
The goal of this study is to characterize the role of androgens in the development of 3D lung structure. Androgens are known as male sex steroids but they exist in the blood of both sexes, although at higher levels for males. We showed in a recent experiment that when the effect of androgens is blocked by administration of a pure antiandrogen (flutamide) to neonatal mice, the last step of lung development (alveolarization) is altered and an obvious defect in lung structure is observed. Surprisingly, our data indicate that flutamide had the same effect in both sexes, showing that androgens are essential for normal lung development of males and females. We know that several genes expressed in the developing lung encode for enzymes showing the capability to synthesize active androgens from an inactive molecule, while other genes produce enzymes able to inactivate androgens. Our hypothesis in this grant is that site-specific expression of the genes involved in androgen synthesis and inactivation results in a multitude of microenvironments with site-specific levels of androgens, which control the development of the 3D structure of the lung. This concept indicates that growth of the lung along each axis (x,y,z) is a tightly orchestrated process. During the next 5 years, I propose to study the involvement of the androgen activating and inactivating genes in lung development: 1) by studying their levels of expression over time during lung development; 2) by characterizing their exact site of expression in the developing lung at different developmental times, and; 3) by examining the lung structure after administration of gene-specific inhibitors (siRNA). This study will be performed in both sexes. The potential of androgens to modulate 3D-lung development makes this fundamental research program very useful for all researchers working on organogenesis and tissue engineering.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2016-05870
Name nom
Tremblay, Yves
Department département
Obstétrique et gynécologie - Obstétrique et gynécologie
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2016
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
102
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal management (animal diseases, breeding)
Area of application fr
Gestion des animaux (maladies animales, reproduction)
Research subject code
5303
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Gene regulation
Research subject fr
Régulation des gènes
Partie
2
Nb partie
5
Application title
STEROID HORMONE SYNTHESIS/INACTIVATION AND ACTION IN TERMINAL LUNG DEVELOPMENT
Keyword
NSERC
Application summary
The goal of this study is to characterize the role of androgens in the development of 3D lung structure. Androgens are known as male sex steroids but they exist in the blood of both sexes, although at higher levels for males. We showed in a recent experiment that when the effect of androgens is blocked by administration of a pure antiandrogen (flutamide) to neonatal mice, the last step of lung development (alveolarization) is altered and an obvious defect in lung structure is observed. Surprisingly, our data indicate that flutamide had the same effect in both sexes, showing that androgens are essential for normal lung development of males and females. We know that several genes expressed in the developing lung encode for enzymes showing the capability to synthesize active androgens from an inactive molecule, while other genes produce enzymes able to inactivate androgens. Our hypothesis in this grant is that site-specific expression of the genes involved in androgen synthesis and inactivation results in a multitude of microenvironments with site-specific levels of androgens, which control the development of the 3D structure of the lung. This concept indicates that growth of the lung along each axis (x,y,z) is a tightly orchestrated process. During the next 5 years, I propose to study the involvement of the androgen activating and inactivating genes in lung development: 1) by studying their levels of expression over time during lung development; 2) by characterizing their exact site of expression in the developing lung at different developmental times, and; 3) by examining the lung structure after administration of gene-specific inhibitors (siRNA). This study will be performed in both sexes. The potential of androgens to modulate 3D-lung development makes this fundamental research program very useful for all researchers working on organogenesis and tissue engineering.